Idorsia Pharmaceuticals Ltd

📍 Allschwil, Switzerland🗓 Founded 2017👥 845 employees💰 Last funded May 2020
Pharmaceutical Manufacturing🌐 idorsia.com
Website LinkedIn
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia privacy policy: https://www.idorsia.com/system/legal-statements/privacy-policy
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in Idorsia Pharmaceuticals Ltd?
Idorsia Pharmaceuticals Ltd has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Idorsia Pharmaceuticals Ltd last raise funding?
The most recent investment in Idorsia Pharmaceuticals Ltd recorded on gritt.io was in May 2020.
When was Idorsia Pharmaceuticals Ltd founded?
Idorsia Pharmaceuticals Ltd was founded in 2017.
What industry is Idorsia Pharmaceuticals Ltd in?
Idorsia Pharmaceuticals Ltd operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Idorsia Pharmaceuticals Ltd based?
Idorsia Pharmaceuticals Ltd is headquartered in Allschwil, Switzerland.